Skip to content

The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans

The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans: a Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07416643
Acronym
AcaciaGlu
Enrollment
14
Registered
2026-02-18
Start date
2023-06-01
Completion date
2023-09-30
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Adult Subjects

Brief summary

Abnormal postprandial blood glucose (PPG) is considered as a strong predictor for developing metabolic diseases worldwide. Nowadays, little understanding is available on how a carbohydrate-rich food matrix and the starch structures within interact with the gastrointestinal tract to help in controlling PPG. In this investigation, the use Acacia gum enriched flour will be used to explore the effect of adding the gum as food supplement on PPG in healthy humans.

Interventions

DIETARY_SUPPLEMENTincorporating acacia gum flour into commonly consume foods

incorporating acacia gum flour into commonly consume foods

Sponsors

King Abdulaziz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female self-reported healthy volunteers (aged 18 to 40 years) * Normal to overweight individuals (body mass index (BMI) 18.5-30 kg/m2) o BMI is equal to body weight (kg) divided by height squared (m2)

Exclusion criteria

* History of substance abuse * Excessive alcohol intake * Pregnancy * Diabetes * Cardiovascular disease * Cancer * Any gastrointestinal disease e.g. irritable bowel syndrome or inflammatory bowel disease * Kidney disease * Liver disease * Pancreatitis * Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.

Design outcomes

Primary

MeasureTime frame
postprandial blood glucose0 minutes and postprandial timepoints: 15 minutes, 30 minutes, 60 minutes,120 minutes,180 minutes

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026